You are here

Women's Imaging


A new study published in the January issue of the Journal of Ultrasound in Medicine has shown that a 3D Doppler ultrasound can more accurately determine altered fetal growth restriction (FGR) in fetuses vulnerable to developing abnormal cerebral vascular flow patterns than a standard 2D Doppler ultrasound.  

Breast cancer mortality rates in the U.S. have decreased by roughly 50 percent from 2000 to 2012, according to a new stimulation modeling study released online Jan. 9 by JAMA.

A Children’s National Health System team has found velocity-selective arterial spin labeling (VSASL), an advanced MRI technology, can detect early signs of global placental perfusion in pregnancies complicated by fetal congenital heart disease (CHD).

The American Institute of Ultrasound in Medicine (AIUM) developed a task force to develop a standardized consensus-based curriculum and competency assessment tools for OB-GYN ultrasounds, with the aim they would be used in residency programs.

Researchers, investigating how community practices are following breast cancer screening guidelines, found that high-risk individuals, especially those with a family history of the disease, were not receiving additional MRI scans to help in early detection.


Recent Headlines

Researchers call for making breast MRI a standalone screening exam

Annual screening mammography adds no value to women who are high risk for breast cancer and, as a matter of course, are already getting screened each year with breast MRI, according to a study conducted at the University of Toronto and published online June 6 in Radiology.

Breast rads meeting, beating or approaching BI-RADS benchmarks for screening MRI

Reviewing screening breast MRI data from six regional Breast Cancer Surveillance Consortium (BCSC) registries representing 49 facilities, researchers have found breast rads performing quite impressively in their respective communities: Their interpretive accuracy from 2005 to 2013 met most BI-RADS benchmarks that are based on expert practice in clinical trials.

Ultrasound breast biopsy beats stereotactic counterpart on patient experience

Women undergoing percutaneous breast biopsy experience less pain and discomfort when the procedure is guided by ultrasound than by stereotactic mammography with vacuum assistance, according to a Canadian study published online May 22 in European Radiology.

Up-and-coming ultrasound technology shows prowess as mammography adjunct

The emerging imaging technology called quantitative transmission (QT) ultrasound has shown its utility as an aid in distinguishing cysts from solid lesions in the breast, according to a study published online May 23 in Academic Radiology.

Fixed date, time for backup appointment improve attendance for women who miss breast cancer screening

Participation in breast cancer screening has declined in England. A new analysis revealed women who miss a first breast screening appointment and are given a fixed date for another appointment are more likely to attend that backup.

Minimally invasive ultrasound-guided biopsy a fine diagnostic for nonpalpable breast lesions

Breast lesions that physicians can’t feel by palpation are little match for fine-needle aspiration guided by ultrasound, although the procedure’s performance varies somewhat with the age of the patient and the BI-RADS category of the lesion.

Regional survey underscores need for more radiologist education on breast density

Many practicing radiologists share the general public’s sense of befuddlement over state-level breast density legislation and its implications for patient care, at least in New England, according to a study published online May 8 in Academic Radiology.

PET/CT bests contrast CT at monitoring metastatic breast cancers

PET/CT is superior to contrast-enhanced CT when it comes to predicting both progression-free and disease-specific survival in patients with metastatic breast cancer, according to a study published online May 1 in the European Journal of Nuclear Medicine and Molecular Imaging.

Nuke/CT recommended upon initial diagnosis of stage IIB breast cancer

Weill Cornell researchers at Memorial Sloan Kettering Cancer Center are recommending the use of PET/CT with the radiotracer fludeoxyglucose (18F-FDG PET/CT) for many patients with newly diagnosed breast cancer.

Nebraska breast density bill signed into law

Nebraska Gov. Pete Ricketts signed Legislative Bill 195 into law today making it the 32nd state to enact mandatory breast density reporting.